Glucagon-like receptor-1 agonists and impotence: A meta-analysis

Table 2 Testicular-pituitary hormones in the included studies

Ref.	TT before GLP-1 agonists	TT, after GLP-1 agonists	FT, before GLP-1 agonists	FT, after GLP-1 agonists	SHBG, before GLP-1 agonists	SHBG, after GLP-1 agonists	LH, before GLP-1 agonists	LH, after GLP-1 agonists	FSH, before GLP-1 agonists	FSH, GLP-1 agonists
Giagull et al[20]	430.8 ± 51.8	450.8 ± 42.4	7.95 ± 1.2	8.3 ± 0.95	37.7 ± 2.4	39.0 ± 1.6	Not assessed	Not assessed	Not assessed	Not assessed
Giagulli et al[21]	259 ± 12	310 ± 37	4.9 ± 0.3	5.6 ± 0.7	34.5 ± 2.20	39.4 ± 1.7	6.6 ± 0.8	6.8 ± 0.4	6.5 ± 0.8	6.8 ± 0.5
Giagulli et al[21]	262 ± 11	328 ± 33	5 ± 0.3	6 ± 0.6	34.6 ± 2.3	39 ± 1.8	6.2. ± 0.7	6.8 ± 2.8	6.6 ± 0.7	6.9 ± 0.5
La Vignera et al[22]	140 ± 60	410 ± 50	5.1 ± 0.64	Not assessed	14 ± 3	36 ± 4	2.3 ± 0.3	3.2 ± 0.2	1.6 ± 0.3	2.6 ± 0.2
Lengsfeld et al[23]	19.7 ± 2.9	20.4. ± 3.2	0.4 ± 0.1	0.4 ± 0.1	36.5 ± 9.69	40.6. ± 4.68	5.2 ± 1.48	4.5 ± 1	3.1 ± 1.83	3.1 ± 1.68
Lisco et al[24]	303.7 ± 41.7	337.7 ± 34.7	5.9 ± 1.3	6.6 ± 0.42	35.4 ± 2.1	39.4 ± 1.7	6.3 ± 0.8	6.8 ± 0.8	6.6 ± 0.7	6.9 ± 0.7

TT: Total; FT: Free testosterone; SHBG: Sex hormone binding globulins; LH: Luteinizing hormone; FSH: Follicular stimulating hormone; GLP-1 agonists: Glucagon-like peptide receptors-1 agonists.